Aspire2B Personalization Pilot Study Program

NCT ID: NCT06191822

Last Updated: 2024-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

3000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aspire2B is a mobile wellness app that uses non-invasive measurements to predict various physiological states and estimate biological age. Users are then enrolled in nutrition, fitness, or sleep challenges within the app that are aimed at improving overall wellness and thus helping to reduce biological age. Mobile health (mHealth) interventions require numerous decisions that integrate behavioral theory, user feedback, and technical and practical feasibility considerations. The main purpose of this research program is to test if the application works as intended. This pilot study program is managed internally by Pepsico clinical researchers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

App Proficiency Behavior Lifestyle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutrition

Set personalized nutrition goals

Group Type OTHER

Nutrition

Intervention Type OTHER

Interact with mobile app and work toward personalized nutrition goals

Fitness

Set personalized fitness goals

Group Type OTHER

Fitness

Intervention Type OTHER

Interact with mobile app and work toward personalized fitness goals

Sleep

Set personalized sleep goals

Group Type OTHER

Sleep

Intervention Type OTHER

Interact with mobile app and work toward personalized sleep goals

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutrition

Interact with mobile app and work toward personalized nutrition goals

Intervention Type OTHER

Fitness

Interact with mobile app and work toward personalized fitness goals

Intervention Type OTHER

Sleep

Interact with mobile app and work toward personalized sleep goals

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fluent in reading and understanding English or Spanish
* Smartphone users

Exclusion Criteria

* Cannot proceed to onboarding without downloading the app, consenting to participate, and agreeing to app Terms of Use
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PepsiCo Global R&D

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tristin Brisbois, PhD, MBS

Role: PRINCIPAL_INVESTIGATOR

PepsiCo Global R&D

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Remote, no facility visits. Managed by PepsiCo R&D Life Sciences

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shellen Goltz, PhD, RD

Role: CONTACT

312-821-3317

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shellen Goltz, PhD, RD

Role: primary

312-821-3317

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEP- 2111/19 - 2302/07/08/09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lifestyle MIND- Feasibility of Wait-list Control
NCT06384521 NOT_YET_RECRUITING NA
Putting CDSMP to Work
NCT02409056 COMPLETED NA
Acute Stress Recovery
NCT05298189 UNKNOWN NA